PACTR201206000391313

The pharmacokinetics of lopinavir/ritonavir, nevirapine and efavirenz when given with isoniazid in South African HIV-infected individuals

Name: Clinical Trial PACTR201206000391313
Creator: University of Cape Town
Keywords: Infections and Infestations; Infections and Infestations, Not Applicable, clinical trial, South Africa

University of Cape Town·Not Applicable·Pan Africa Clinical Trials RegistryRecruiting

Study focus

Disease/Condition: Infections and Infestations; Infections and Infestations

Sponsor & location

Primary sponsor: University of Cape Town
Funder: South African Medical Research Council
Location: South Africa

Timeline & enrollment

Phase: Not Applicable
Start date: Jan 01, 1900
End date: Jan 01, 1900

Summary

INH has been shown to inhibit various cytochrome P450 (CYP) isoforms including CYP3A4.IPT and ART have complementary roles for tuberculosis prevention and is likely to be a priority intervention as part of of HIV treatment. We propose to study the pharmacokinetics of INH when administered with ART, specifically NVP, EFV and LPV/r.

ICD-10 classifications

Certain infectious and parasitic diseasesInfestation, unspecifiedOther specified infestationsOther infestationsSequelae of infectious and parasitic diseases

Data source

Registry: Pan Africa Clinical Trials Registry
Trial ID: PACTR201206000391313
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for PACTR201206000391313 through Pure Global AI's free database. This Not Applicable trial is sponsored by University of Cape Town and is currently Recruiting. The study focuses on Infections and Infestations; Infections and Infestations.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.